YSB Inc. (HKG: 9885)

Market Cap	4.64B
Revenue (ttm)	19.14B
Net Income (ttm)	1.29M
Shares Out	643.00M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	105,200
Open	7.36
Previous Close	n/a
Day's Range	n/a
52-Week Range	5.91 - 59.55
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 26, 2024

About YSB Inc.

YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company develops ClouDiagnos for diagnostic testing service; wePharmacy, a 24-hour access smart unmanned pharmaceutical booth that connects buyers and the end customers with pharmacist services; SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. It also engages in the wholesale and retail of pharmaceutical an...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2015
• Employees: 6,306
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9885

Financial Performance

In 2023, YSB Inc.'s revenue was 16.97 billion, an increase of 18.90% compared to the previous year's 14.27 billion. Losses were -3.19 billion, 114.2% more than in 2022.

Financial numbers in CNY